It was previously reported that anti-GSK3β treatments in other cancer types, including pancreatic cancer and glioblastoma, sensitize the cells to chemotherapeutic reagents and ionizing radiation [37–40]. The gene discussed is GSK3B; the disease is pancreatic neoplasm.